Researchers from the University of Cambridge have developed a novel approach to diagnosing bipolar disorder using an online psychiatric assessment combined with a blood test. This new method aims to differentiate bipolar disorder from major depressive disorder, which often presents similar symptoms. The blood test alone can accurately diagnose up to 30% of bipolar disorder cases, but it is even more effective when used in conjunction with the digital assessment. This diagnostic tool not only provides a faster and more accurate diagnosis but also offers insight into the biological basis of bipolar disorder. Currently, nearly 40% of bipolar disorder cases are misdiagnosed as major depressive disorder, affecting millions of people worldwide. The combination of patient-reported information and the biomarker test significantly improves diagnostic outcomes for individuals with bipolar disorder, especially in cases where the diagnosis may not be obvious. This new method could help clinicians differentiate between the two conditions and ensure that patients receive the appropriate treatment. In addition, the biomarker testing used in this study could potentially identify new drug targets for mood disorders, leading to better treatments in the future.
8